Dow +0.11% 18868Pts, Nasdaq -0.36 % a 5218pts , S&P -0.01% 2164pts

| $CRBP |
|
|
|
|
|
|
| Corbus
Pharmaceuticals Holdings Inc |
|
|
|
|
| Industria:
Biotecnología |
|
|
|
|
|
| Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$CRBP
subio 51.28% a $8.85 , luego de anunciar avances en el tratamiento de la
esclerosis mùltiples


| $DVAX |
|
|
|
|
|
|
| Dynavax
Technologies Corporation |
|
|
|
|
| Industria:
Biotecnologia |
|
|
|
|
|
| Sector: Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
| $DVAX bajò 64.66% a
$4.10, despues de anunciar que su ensayo para el tratamiento de la
hepatitis B |
| no alcanzò
los objetivos primarios |
|
|
|
|

| Otros Stocks: |
|
|
|
|
|
| $DRYS
, $EGLE , $HAR , $IDSA , $RSO , $HEAR , $PBYI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No hay comentarios:
Publicar un comentario